Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.38M
-
Shares change
-
+72.1K
-
Total reported value, excl. options
-
$5.76M
-
Value change
-
+$298K
-
Put/Call ratio
-
0.92
-
Number of buys
-
8
-
Number of sells
-
-14
-
Price
-
$4.19
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q1 2023
33 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q1 2023.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.38M shares
of 101M outstanding shares and own 1.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (574K shares), GEODE CAPITAL MANAGEMENT, LLC (145K shares), EMC Capital Management (124K shares), COLONY GROUP LLC (93K shares), BlackRock Inc. (85K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (73.1K shares), TANG CAPITAL MANAGEMENT LLC (53.2K shares), STATE STREET CORP (44.4K shares), MILLENNIUM MANAGEMENT LLC (38.4K shares), and SABBY MANAGEMENT, LLC (28.6K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.